Data Year:

For its 2025 fiscal year, INSPIRE MEDICAL SYSTEM, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2025
Name And Title Total Compensation Pay Rank By Title In MFG Durable industry
Richard J. Buchholz
Chief Financial Officer
Total Compensation $2,707,684 View details Pay Rank By Title In MFG Durable industry #282 View more
Timothy P. Herbert
President and Chief Executive Officer
Total Compensation $7,711,784 View details Pay Rank By Title In MFG Durable industry #282 View more
Randall A. Ban
Chief Commercial Officer
Total Compensation $2,729,288 View details Pay Rank By Title In MFG Durable industry #77 View more
Bryan K. Phillips
SVP, General Counsel, CCO and Corporate Secretary
Total Compensation $2,702,485 View details Pay Rank By Title In MFG Durable industry #50 View more
Carlton W. Weatherby
Chief Strategy Officer
Total Compensation $2,835,087 View details Pay Rank By Title In MFG Durable industry #71 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at INSPIRE MEDICAL SYSTEM as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. INSPIRE MEDICAL SYSTEM income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. INSPIRE MEDICAL SYSTEM annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Richard J. Buchholz
Chief Financial Officer
Total Cash $797,477 Equity $1,899,947 Other $10,260 $2,707,684
Timothy P. Herbert
President and Chief Executive Officer
Total Cash $1,712,129 Equity $5,999,655 Other $0 $7,711,784
Randall A. Ban
Chief Commercial Officer
Total Cash $818,841 Equity $1,899,947 Other $10,500 $2,729,288
Bryan K. Phillips
SVP, General Counsel, CCO and Corporate Secretary
Total Cash $792,794 Equity $1,899,947 Other $9,744 $2,702,485
Carlton W. Weatherby
Chief Strategy Officer
Total Cash $935,140 Equity $1,899,947 Other $0 $2,835,087
For its 2025 fiscal year, INSPIRE MEDICAL SYSTEM, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Timothy P. Herbert CEO Pay $7,711,784 Median Employee Pay $222,549 CEO Pay Ratio 35:1
For its 2024 fiscal year, INSPIRE MEDICAL SYSTEM, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Casey M. Tansey Total Cash $237,500
Cynthia B. Burks Total Cash $237,500
Dana G. Mead, Jr. Total Cash $246,216
Gary L. Ellis Total Cash $266,187
Georgia Garinois-Melenikiotou Total Cash $240,000
Jerry C. Griffin, M.D. Total Cash $19,430
Marilyn Carlson Nelson Total Cash $33,791
Myriam J. Curet, M.D. Total Cash $237,500
Shawn T McCormick Total Cash $250,000
Shelley G. Broader Total Cash $245,000
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.